Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis
BackgroundIschemic stroke is the second leading cause of death and the third leading cause of combined disability and mortality globally. While reperfusion therapies play a critical role in the management of acute ischemic stroke (AIS), their applicability is limited, leaving many patients with sign...
Saved in:
| Main Authors: | Yuchen Wang, Mengqi Li, Yuye Jiang, Qiuhong Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2024.1530987/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peculiarities of neuroprotective therapy in women with acute ischemic stroke
by: O. A. Halushko, et al.
Published: (2020-08-01) -
Edaravone's Safety Profile in Acute Ischemic Stroke
by: Laurence K. J. Batino, et al.
Published: (2024-12-01) -
Neuroprotective effect and possible mechanism of edaravone in rat models of spinal cord injury: a systematic review and network meta-analysis
by: Long-yun Zhou, et al.
Published: (2025-04-01) -
Edaravone Dexborneol provides neuroprotective effect by inhibiting neurotoxic activation of astrocytes through inhibiting NF-κB signaling in cortical ischemia
by: Zhe Chen, et al.
Published: (2024-11-01) -
Evaluation of the neuroprotective activity of a new allylmorpholine derivative in a rat model of traumatic brain injury
by: V. A. Prikhodko, et al.
Published: (2021-12-01)